All Curated Mutation Sites in HBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
S
  
BCP
  
X
  
C
  
Core Promoter
  
Core Upstream Regulatory Sequence
  
DR1
  
EnhI
  
EnhII
  
PreC
  
P
  
PreC Promoter
  
PreS
  
PreS1
  
PreS1 Promoter
  
PreS2
  
RT
  
S Promoter
  
S1 Promoter
  
S2 Promoter
  
X Promoter
  

Keyword: Liver Diseases-17503077
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 17503077 C76F
S
S
Liver Diseases
G
L
View
2 17503077 S143T
S
S
Liver Diseases
G
L
View
3 17503077 A184V
S
S
Liver Diseases
G
L
View
4 17503077 A53V
PreS2
S
Liver Diseases
G
L
View
5 17503077 D51G
PreS2
S
Liver Diseases
G
L
View
6 17503077 F46S
PreS2
S
Liver Diseases
G
L
View
7 17503077 F83C
S
S
Liver Diseases
G
L
View
8 17503077 I49T
PreS2
S
Liver Diseases
G
L
View
9 17503077 L127P
S
S
Liver Diseases
G
L
View
10 17503077 L49R
PreS1
S
Liver Diseases
G
L
View
11 17503077 N48T
PreS1
S
Liver Diseases
G
L
View
12 17503077 P54L
PreS2
S
Liver Diseases
G
L
View
13 17503077 Q82P
PreS1
S
Liver Diseases
G
L
View
14 17503077 S204N
S
S
Liver Diseases
G
L
View
15 17503077 T189I
S
S
Liver Diseases
G
L
View
16 17503077 V14A
PreS1
S
Liver Diseases
G
L
View
17 17503077 V224A
S
S
Liver Diseases
G
L
View
18 17503077 A39V
PreS2
S
Liver Diseases
G
L
View
19 17503077 D91N
PreS1
S
Liver Diseases
G
L
View
20 17503077 E54D
PreS1
S
Liver Diseases
G
L
View
21 17503077 E54Q
PreS1
S
Liver Diseases
G
L
View
22 17503077 F67L
PreS1
S
Liver Diseases
G
L
View
23 17503077 F67S
PreS1
S
Liver Diseases
G
L
View
24 17503077 F82C
S
S
Liver Diseases
G
L
View
25 17503077 F85L
S
S
Liver Diseases
G
L
View
26 17503077 H16Q
PreS1
S
Liver Diseases
G
L
View
27 17503077 H86A
PreS1
S
Liver Diseases
G
L
View
28 17503077 I213T
S
S
Liver Diseases
G
L
View
29 17503077 I82T
S
S
Liver Diseases
G
L
View
30 17503077 K86Q
PreS1
S
Liver Diseases
G
L
View
31 17503077 K86T
PreS1
S
Liver Diseases
G
L
View
32 17503077 P203Q
S
S
Liver Diseases
G
L
View
33 17503077 P52L
PreS2
S
Liver Diseases
G
L
View
34 17503077 P70T
S
S
Liver Diseases
G
L
View
35 17503077 P93Q
PreS1
S
Liver Diseases
G
L
View
36 17503077 P94L
PreS1
S
Liver Diseases
G
L
View
37 17503077 R122K
S
S
Liver Diseases
G
L
View
38 17503077 R35K
PreS1
S
Liver Diseases
G
L
View
39 17503077 S77W
PreS1
S
Liver Diseases
G
L
View
40 17503077 S96A
PreS1
S
Liver Diseases
G
L
View
41 17503077 S96F
PreS1
S
Liver Diseases
G
L
View
42 17503077 T19S
PreS1
S
Liver Diseases
G
L
View
43 17503077 T31A
PreS2
S
Liver Diseases
G
L
View
44 17503077 T53K
PreS1
S
Liver Diseases
G
L
View
45 17503077 T97N
PreS1
S
Liver Diseases
G
L
View
46 17503077 W77T
PreS1
S
Liver Diseases
G
L
View
47 17503077 Y206H
S
S
Liver Diseases
G
L
View
Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.